Tag: Odefsey

EU nod for Gilead’s single-pill HIV therapy

by Selina McKee | Jun 24, 2016 | News | 0

European regulators have granted marketing authorisation to Gilead’s Odefsey for the treatment of certain patients with HIV-1 infection.

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999